Two Keynote Speakers confirmed for The Antibody Series 2025 Conference
The highly anticipated 2025 edition of the Antibody Series has confirmed two distinguished keynote speakers set to headline its Scientific Program.
Professor Annemiek van Spriel, a leading expert in immunology from Radboud University Medical Center, will deliver a keynote lecture titled “Tetraspanin microdomains: a novel target in B cell lymphoma”. Her groundbreaking research focuses on the role of tetraspanins in immune cell function and cancer, offering promising new directions for therapeutic strategies in lymphoma.
Joining her is Dr. Peter Senter, Vice President of Chemistry at Seagen Inc., who will present “Antibody-Drug Conjugates: From Bench to Bedside”. A pioneer in the development of ADCs, Dr. Senter will share insights into the evolution, challenges, and future of this transformative therapeutic approach.
The 2025 Antibody Series, set to gather the world’s leading minds in antibody R&D, promises cutting-edge discussions and collaboration. Full program details are available at antibodyseries.com.
Confirmed Keynote Speakers – The Antibody Series 2025
Two Keynote Speakers confirmed for The Antibody Series 2025 Conference The highly anticipated 2025 edition of the Antibody Series has confirmed two distinguished keynote speakers set to headline its Scientific Program. Professor Annemiek van Spriel, a leading expert in immunology from Radboud University Medical Center, will deliver a keynote lecture titled “Tetraspanin microdomains: a novel target in B cell lymphoma”. Her groundbreaking research focuses on the role of tetraspanins in immune cell function and cancer, offering promising new directions for therapeutic strategies
Dr. Janine Schuurman Appointed Chairwoman of The Antibody Series 2025
Janine Schuurman to compose agenda for the conference’s special 5th anniversary edition On-demand lectures now available from 2024’s edition Porto, Portugal – 9th January 2025: The Antibody Series (TAS), a leading international conference focused on innovation and advancing the field of antibody discovery and development, is pleased to announce Dr. Janine Schuurman as Chair of the highly anticipated 5th edition. The conference will take place from September 9-12, 2025, in Porto, Portugal. Dr. Schuurman, an esteemed expert in the antibody field,
Save the Date for TAS 2025
FairJourney Biologics Announces Special 5th Anniversary Edition of The Antibody Series in Porto, Portugal - Official dates released 9 – 12 September 2025 - On-demand now available from 2024’s Edition Porto, Portugal – FairJourney Biologics is excited to announce official dates for the highly anticipated return of The Antibody Series conference next year, confirmed for September 9-12, 2025 and returning to Porto, Portugal. The 5th anniversary edition promises to be a very special milestone event in continuing to bring together leading experts in
Your Guide to Joining TAS 2024
Everything you need to know about the 4th edition of The Antibody Series Overview Details In-person: 4 – 6 September, 2024 Location: Madeira Island, Portugal Free on-demand: Register here Chairman: Dr. Paul Parren, CSO at Gye About The Antibody Series is the fastest growing antibody conference of its kind. Started in 2021, in Porto, Portugal, the premier annual conference brings together international experts in the field of antibody discovery and development to discuss innovative topics and trends in the industry. Attendees benefit from
Dr Paul Parren announced as Chairman of TAS 2024
Dr Paul Parren is dedicated to translating antibody knowledge into innovative therapeutics and technologies. Holding a PhD in molecular immunology from the University of Amsterdam (1992), Prof. Paul Parren is the founder and CSO at Gyes BV, a start-up company pioneering multispecific antibodies.
